Some studies have suggested thymic tumor ERα immunoreactivity is correlated with reduced tumor size, clinical stage, and improved overall outcomes; high expression of ERβ in thymic tumors and a significant association with clinical stage have also been observed. Here, ESR2 is linked to thymus neoplasm.